Jan 17, 2018 21:05 pm UTC| Business
PEMBROKE, Bermuda, Jan. 17, 2018 -- James River (NASDAQ:JRVR) announced today it will release its earnings for the quarter and year ended December 31, 2017 after the market closes on Thursday, February 22, 2018. The...
Franklin Limited Duration Income Trust Declares Monthly Distribution
Jan 17, 2018 21:05 pm UTC| Business
SAN MATEO, Calif., Jan. 17, 2018 -- Franklin Limited Duration Income Trust (NYSE American:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today a distribution of $0.1034 per common...
Franklin Universal Trust Declares Monthly Distribution
Jan 17, 2018 21:05 pm UTC| Business
SAN MATEO, Calif., Jan. 17, 2018 -- Franklin Universal Trust (NYSE:FT), a closed-end investment company managed by Franklin Advisers, Inc., announced today a distribution of $0.032 per share, payable February 15, 2018,...
Jan 17, 2018 21:05 pm UTC| Business
IRVINE, Calif., Jan. 17, 2018 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief...
Black Knight Announces Fourth Quarter and Full-Year 2017 Earnings Release and Conference Call
Jan 17, 2018 21:05 pm UTC| Business
JACKSONVILLE, Fla., Jan. 17, 2018 -- Black Knight, Inc. (NYSE:BKI), a leading provider of software, data and analytics solutions to the mortgage and consumer loan, real estate and capital markets verticals, will release...
Mistras Group, Inc. Reaffirms Expected 2017 Results and Sets Initial 2018 Outlook
Jan 17, 2018 21:01 pm UTC| Business
PRINCETON JUNCTION, N.J., Jan. 17, 2018 -- Mistras Group, Inc. (NYSE:MG), a leading "one source" global provider of technology-enabled asset protection solutions, today reaffirmed its expectation for 2017 results and...
Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Spain
Jan 17, 2018 21:01 pm UTC| Business
CRANBURY, N.J. and MADRID, Spain, Jan. 17, 2018 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision...